Join Now

Author Archives: Press Release

U.S. Patent Office Grants New Patent Protection For Exoskeleton Focal-Force Angioplasty Platform

Transit Scientific achieved increased U.S. patent protection for their novel exoskeleton focal-force angioplasty technology using standard off-the-shelf peripheral transluminal angioplasty (PTA) balloons.

Posted in BioUtah News | Tagged | Leave a comment

CenExel Acquires Apex Innovative Sciences

Premier CNS-Focused Research Facilities in California and New Jersey Join the CenExel Centers of Excellence Clinical Research Site Network

Posted in BioUtah News | Tagged | Leave a comment

Sen. Romney Opposes Drug Importation as the Senate HELP Committee Advances User Fees

The Senate Health, Education, Labor and Pensions (HELP) Committee voted 13 to 9 on Tuesday to advance user fee reauthorization legislation.

Posted in BioUtah News, Policy News | Leave a comment

Halia Therapeutics Announces First Participant Dosed in Phase 1 Clinical Study of HT-6184

HT-6184 is a novel NEK7/NLRP3 inhibitor

Posted in BioUtah News | Tagged | Leave a comment

BD Collaborates with Mayo Clinic Platform, Leveraging Real-World Clinical Data to Improve Post-Market Device Surveillance, Drive Innovation for Patient Care

BD is among the first companies to enter innovative partnership with Mayo Clinic Platform for access to world’s largest collection of clinical data

Posted in BioUtah News | Tagged | Leave a comment

CerTest Biotec and BD Announce Collaboration on Molecular Diagnostic Test for Monkeypox

CerTest Biotec Uses the BD MAX™ Molecular Diagnostic System Open System Reagent Suite to Develop RT-PCR Detection Kit

Posted in BioUtah News | Tagged | Leave a comment

BD TO ACQUIRE PARATA SYSTEMS TO ENTER NEW PHARMACY AUTOMATION SOLUTIONS MARKET

Expands BD Transformative Solutions to Provide New Pharmacy Automation Technologies for Hospitals, Retail Pharmacy, Long-Term Care and Home Settings Advances BD 2025 Strategy to Accelerate Innovation in Smart, Connected Care and Enable New Care Settings Expected to be Immediately Accretive to Revenue Growth, Adjusted Operating Margins and Adjusted EPS; Enhances Ability to Achieve Long-Range Sales […]

Posted in BioUtah News | Tagged | Leave a comment

KidneyIntelX™ Demonstrates Ability to Assess Risk of Heart Failure Hospitalization and Death in Large International Diabetic Kidney Disease Patient Cohort

Data shared in oral presentation at American Diabetes Association 82nd Scientific Sessions® and published in Kidney360 highlights importance in early understanding of cardiovascular risk, a leading cause of death in patients with diabetes and chronic kidney disease

Posted in BioUtah News | Tagged | Leave a comment

PolarityTE Announces $8.0 Million Registered Direct and Private Placement Offerings Priced At-The-Market Under Nasdaq Rules

PolarityTE announced that it has entered into securities purchase agreements with a single healthcare-focused institutional investor

Posted in BioUtah News | Tagged | Leave a comment

Civica Selects Profil as Clinical Trial Partner for Affordable Insulin Initiative

Profil has conducted over 30 biosimilar insulin trials and is the leading clinical research organization for studies related to diabetes.

Posted in BioUtah News | Tagged | Leave a comment

Biomerics announces expansion in Ireland with a new facility in Galway

BIOMERICS ANNOUNCES EXPANSION INTO IRELAND Expanding High-Performance Balloon Design & Development Capabilities in Galway

Posted in BioUtah News | Tagged | Leave a comment

Co-Diagnostics, Inc. Completes Principal Design of Test for Monkeypox Virus

Co-Diagnostics announced that it has completed the principal design work of a PCR test for the monkeypox virus currently exhibiting a multi-country outbreak.

Posted in BioUtah News | Tagged , | Leave a comment